Rays of Belief, the parent company of Mom's Belief, will open its IPO on September 1, 2026, to raise ₹125 crore. The funds are earmarked for expanding its network by 319 centers by fiscal 2029. Investors may want to analyze the company's rapid revenue growth alongside the recent dip in net profit.
Rays of Belief Ltd., which operates the neurodevelopmental therapy brand Mom's Belief, is set to launch its initial public offering on September 1, 2026. The issue will remain open until September 3, 2026, with a price band fixed between ₹227 and ₹239 per equity share. The company aims to raise approximately ₹125 crore through a fresh issue of up to 5.23 million shares, which will be listed on both the BSE and the NSE.
Business Expansion and Financial Context
The primary objective of this fundraising is to fuel a significant expansion phase. As of March 31, 2026, the company operated 136 centers across 57 cities. The management has outlined an ambitious plan to establish 319 additional centers between fiscal years 2027 and 2029. A portion of the proceeds from this IPO will be directed toward setting up these locations, including expenditures for center fit-outs, therapy materials, and technology infrastructure.
Investors looking at the company's financial health will note a trend of strong top-line growth paired with recent pressure on the bottom line. In fiscal year 2026, the company’s consolidated revenue from operations doubled to ₹81.66 crore, compared to ₹36.42 crore in the previous fiscal year. However, profit for the year experienced a decline, falling to ₹4.96 crore in fiscal 2026 from ₹5.88 crore in fiscal 2025. This divergence between revenue and profit is a key area for analysis, as aggressive scaling and the costs associated with launching new centers often impact margins in the short term.
Operational Risks and Monitorables
The company’s future performance rests heavily on its ability to execute its expansion strategy without incurring excessive operational costs. Scaling from 136 centers to over 450 total locations in a few years is an ambitious task that requires efficient management of human resources, space, and operational overheads. Because the company relies on leased premises to operate its centers, any significant increase in rental costs or difficulties in securing suitable locations in target cities could compress profit margins.
Furthermore, the success of the business is linked to the niche market of neurodevelopmental care, which includes providing specialized therapy for autism, ADHD, and other developmental disorders. Maintaining service quality and consistency across a rapidly expanding network will be a critical operational hurdle. Investors may track the company's ability to stabilize its profit margins as it scales, as well as the progress of the planned 319 new center rollouts against the management's timeline.